EMA Informs On Actions To Prevent Brexit-Related Shortages
Executive Summary
A Q&A document has been released by the EMA outlining measures EU authorities are taking to prevent medicine shortages as a result of Brexit. Safety, medicine evaluation, clinical trials and supplies are all topics that are addressed in the text.